JP2025511126A - ケノデオキシコール酸ナトリウムの形態及び組成物 - Google Patents

ケノデオキシコール酸ナトリウムの形態及び組成物 Download PDF

Info

Publication number
JP2025511126A
JP2025511126A JP2024557921A JP2024557921A JP2025511126A JP 2025511126 A JP2025511126 A JP 2025511126A JP 2024557921 A JP2024557921 A JP 2024557921A JP 2024557921 A JP2024557921 A JP 2024557921A JP 2025511126 A JP2025511126 A JP 2025511126A
Authority
JP
Japan
Prior art keywords
solid form
peaks
xrpd pattern
theta
degrees
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024557921A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025511126A5 (https=
Inventor
カテリーナ ナポレターノ，
マルコ マリノ，
キアラ ヴラディスコビッチ，
アレッサンドロ レステッリ，
コリーナ－ミハエラ マンタ，
アンドレイ－アルネル パトラシュク，
Original Assignee
シンティス バイオ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT102022000006161A external-priority patent/IT202200006161A1/it
Priority claimed from IT102022000019725A external-priority patent/IT202200019725A1/it
Application filed by シンティス バイオ， インコーポレイテッド filed Critical シンティス バイオ， インコーポレイテッド
Publication of JP2025511126A publication Critical patent/JP2025511126A/ja
Publication of JP2025511126A5 publication Critical patent/JP2025511126A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024557921A 2022-03-29 2023-03-28 ケノデオキシコール酸ナトリウムの形態及び組成物 Pending JP2025511126A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IT102022000006161A IT202200006161A1 (it) 2022-03-29 2022-03-29 Forms and compositions of sodium chenodeoxycholate
IT102022000006161 2022-03-29
IT102022000019725 2022-09-26
IT102022000019725A IT202200019725A1 (it) 2022-09-26 2022-09-26 Forme e composizioni del chenodeossicolato di sodio
PCT/US2023/016486 WO2023192221A1 (en) 2022-03-29 2023-03-28 Forms and compositions of sodium chenodeoxycholate

Publications (2)

Publication Number Publication Date
JP2025511126A true JP2025511126A (ja) 2025-04-15
JP2025511126A5 JP2025511126A5 (https=) 2026-04-07

Family

ID=88203205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024557921A Pending JP2025511126A (ja) 2022-03-29 2023-03-28 ケノデオキシコール酸ナトリウムの形態及び組成物

Country Status (5)

Country Link
US (1) US20250206773A1 (https=)
EP (1) EP4499660A1 (https=)
JP (1) JP2025511126A (https=)
CN (1) CN119213007A (https=)
WO (1) WO2023192221A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7814075B1 (ja) * 2025-09-18 2026-02-16 株式会社フジモト・コーポレーション 錠剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102580A1 (en) * 2011-09-22 2013-04-25 Kythera Biopharmaceuticals, Inc. Compositions and methods related to deoxycholic acid and its polymorphs
TW201704251A (zh) * 2015-04-29 2017-02-01 正大天晴藥業集團股份有限公司 鵝去氧膽酸衍生物
CN109762043B (zh) * 2019-03-06 2020-07-24 华南理工大学 鹅去氧胆酸及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7814075B1 (ja) * 2025-09-18 2026-02-16 株式会社フジモト・コーポレーション 錠剤

Also Published As

Publication number Publication date
EP4499660A1 (en) 2025-02-05
US20250206773A1 (en) 2025-06-26
CN119213007A (zh) 2024-12-27
WO2023192221A1 (en) 2023-10-05

Similar Documents

Publication Publication Date Title
CN105873586B (zh) 一种包含缬沙坦和ahu377的三钠盐超分子复合物的晶型及其制备方法
JP6359971B2 (ja) イバブラジン塩酸塩の形態ｉｖ
CN105175473A (zh) 一种奥贝胆酸晶型i及其制备方法、药物组合物和用途
WO2022258060A1 (zh) 一种lanifibranor的晶型及其制备方法
JP2015522010A (ja) リファキシミン及びアミノ酸を含む医薬組成物、その調製方法及びその使用
US11286259B2 (en) Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof
JP2023550428A (ja) インテグリン阻害剤およびその使用
JP2023503833A (ja) タファミジスの結晶形及びその調製方法及びその使用
CN110621662A (zh) 一种盐的结晶性固体形式、制备工艺和使用方法
WO2018184185A1 (zh) 奥扎莫德加成盐晶型、制备方法及药物组合物和用途
JP2021504437A (ja) ４−アミノ−ｎ−（１−（（３−クロロ−２−フルオロフェニル）アミノ）−６−メチルイソキノリン−５−イル）チエノ［３，２−ｄ］ピリミジン−７−カルボキサミドの塩とその結晶形態
IL323665A (en) S1P1 receptor agonist, its salt, crystalline form, and pharmaceutical composition
JP2025511126A (ja) ケノデオキシコール酸ナトリウムの形態及び組成物
JP2024539726A (ja) Ｎ－（（１ｒ，３ｓ）－３－（４－アセチルピペラジン－１－イル）シクロヘキシル）－４－フルオロ－７－メチル－１ｈ－インドール－２－カルボキサミドの結晶形態
SK8312002A3 (en) Novel forms of pravastatin sodium
WO2014036865A1 (zh) 芬戈莫德粘酸盐及其晶体的制备方法和用途
CN106632564A (zh) 奥贝胆酸盐及其无定形物和药物组合物
TWI705065B (zh) 嗎啉衍生物的鹽及其晶型、其製備方法及藥物組成物、用途
WO2013174035A1 (zh) 一种制备磷酸西他列汀无水晶型i的方法
ES2324281T3 (es) Eteres de dicarboxilato de calcio, procedimientos de fabricacion de los mismos.
CN112778290B (zh) 一种s1p1受体激动剂的加成盐及其晶型和药物组合物
EP2397458A1 (en) Organic salts and co-crystals of phenylbutyric acid
US20240391885A1 (en) Forms of linerixibat
TW202248189A (zh) 芬戈莫德藥用鹽、製備方法、含其的藥物組合物及應用
WO2023137966A1 (zh) 一种徳拉沙星葡甲胺盐新晶型及其制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260330